Norfolk Hospital Joins Groundbreaking Generation Study Here at Maly IT, we’re really pleased to hear that our local Norfolk and Norwich University Hospital (NNUH) is taking part in the pioneering Generation Study. This national research project aims to transform how over 200 rare genetic conditions are diagnosed in newborns. The study will offer whole genome […]
Building upon Part 1’s exploration of product labelling as a defence against counterfeiting, this article (Part 2) delves into the intricate process of managing pharmaceutical labelling changes, crucial for compliance, minimising waste, and maintaining efficient supply chains across multiple markets. The seemingly simple act of changing a word or updating a logo on a pharmaceutical
Previously in Part 1, we identified examples from the bewildering array of different types of business process management tools. Let’s now explore some of the main challenges companies raise with these tools and how to overcome them. We’ll start with challenges directly related to the nature, adoption and use of these tools: 1. Complexity and
As businesses grow and mature they develop ever more processes that increase in length (number of steps), complexity (number of decision points & branches), actors (people required to interact with the process) and touchpoints (interactions with other data sets, applications or systems). Keeping track of and monitoring all of these processes as they grow and
The ability to visually and digitally verify a product is genuine, is a vital part of the combat against counterfeit products, argues Richard Maly. In the high-stakes realm of biotechnology and pharmaceuticals, where precision and patient safety are paramount, product labelling transcends mere information provision. It becomes a critical line of defence against the insidious
You may have missed this news headline amongst all of the global upheaval we’ve been bombarded with recently. This was yet another eye-opening and serious example of what can go catastrophically wrong if your business suffers a process compliance failure. Somehow 110,000 packs of Boots medication (Paracetamol in this case) reached the shop shelves with
The biopharmaceutical landscape is undergoing a significant transformation, driven by the increasing reliance on in silico simulations in drug discovery and therapeutics development. This computational approach offers a powerful tool for researchers. It allows for the prediction of drug-target interactions. Lead compounds can be optimised. The behaviour of molecules within biological systems can be simulated.
Process innovation involves the introduction of new or significantly improved production techniques, equipment, or software, fundamentally changing how products are made. In advanced manufacturing, this can mean the integration of robotics, artificial intelligence (AI), and data analytics to optimize operations & enhance productivity. Benefits include: Increased Productivity – By automating repetitive tasks & using advanced
Process compliance is crucial in new drug development and testing as it ensures that all regulatory requirements are met at each stage, from discovery to post-marketing surveillance. Compliance involves rigorous scientific research, data integrity, and adherence to Good Manufacturing Practices (GMP) and regulatory submissions such as the Clinical Trial Application (CTA) (Investigational New Drug –
